Showing results (121-130 of 536) with videos related to
Sort By:
Pageof 54
Pharmacoeconomics|April 17, 2001
Rivastigmine. A pharmacoeconomic review of its use in Alzheimer's diseaseH M Lamb, K L GoaDrugs|July 24, 2001
Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipientsJ K McGavin, K L GoaPaediatric Drugs|August 11, 2000
Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infectionA J Matheson, K L GoaDrugs|June 1, 1994
Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone diseaseG L Plosker, K L GoaBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Recombinant interferon-beta-1a: a review of its therapeutic efficacy in relapsing-remitting multiple sclerosisA J Wagstaff, K L GoaDrugs|March 1, 1991
Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illnessR J Milne, K L GoaDrugs|September 1, 1991
Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failureJ A Balfour, K L GoaDrugs|December 1, 1991
Flumazenil. A reappraisal of its pharmacological properties and therapeutic efficacy as a benzodiazepine antagonistR N Brogden, K L GoaDrugs|February 1, 1993
Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disordersK J Palmer, K L GoaDrugs|April 1, 1992
Moclobemide. A review of its pharmacological properties and therapeutic use in depressive illnessA Fitton, D Faulds, K L GoaPageof 54